Company Filing History:
Years Active: 2023
Title: Jagbir Singh: Innovator in Transfection Technology
Introduction
Jagbir Singh is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of transfection reagents. His work focuses on enhancing the delivery of nucleic acids into resistant cell types, which is crucial for various therapeutic applications.
Latest Patents
Jagbir Singh holds a patent for "Compositions for transfecting resistant cell types." This innovative transfection reagent composition comprises 30-60 MOL. % of a cationic lipid, or a pharmaceutical acceptable salt thereof; 10-60 MOL % of a structural lipid; 10-20 MOL % of a triglyceride; and 0.1 to about 10 MOL. % of a stabilizing agent. The transfection agent is particularly effective in transfecting cells, especially neurons, with siRNA, mRNA, and plasmid nucleic acid, while maintaining the viability of the cells and the activity of the delivered nucleic acid.
Career Highlights
Throughout his career, Jagbir Singh has worked with leading companies in the biotechnology sector, including Precision Nanosystems ULC and Precision Nanosystems Inc. His expertise in transfection technology has positioned him as a valuable asset in the field.
Collaborations
Jagbir has collaborated with talented individuals such as Anitha Thomas and Rebecca Anne Grace De Souza, contributing to advancements in transfection methodologies.
Conclusion
Jagbir Singh's innovative work in transfection technology has the potential to significantly impact the field of biotechnology. His contributions are paving the way for new therapeutic approaches and enhancing the effectiveness of nucleic acid delivery systems.